Characterization of currently marketed heparin products: Analysis of heparin digests by RPIP-UHPLC-QTOF-MS

Journal of Pharmaceutical and Biomedical Analysis

Volumn 67-68, Issue , 2012, Pages 42-50

  Wang, Bo ^a   Buhse, Lucinda F ^a   Al Hakim, Ali ^b   Ii, Michael T Boyne ^a   Keire, David A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b CDER   (United States)

Author keywords

Heparin; LMWH; QTOF MS; RPIP; UHPLC

Indexed keywords

DALTEPARIN; DISACCHARIDE; ENOXAPARIN; HEPARIN LYASE; LOW MOLECULAR WEIGHT HEPARIN; TINZAPARIN;

ARTICLE; CARBOHYDRATE ANALYSIS; DRUG MARKETING; DRUG METABOLISM; ELECTROSPRAY; FLAVOBACTERIUM; FLAVOBACTERIUM HEPARINUM; ION PAIR CHROMATOGRAPHY; ION TRAP MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVERSE PHASE ION PAIRING LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEPARIN; LIMIT OF DETECTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84862153308     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.04.033     Document Type: Article

References (40)

1. Sommers C.D., Ye H.P., Kolinski R.E., Nasr M., Buhse L.F., Al-Hakim A., Keire D.A. Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns. Anal. Bioanal. Chem. 2011, 401:2445-2454.
2. Young G. New anticoagulants in children: a review of recent studies and a look to the future. Thromb. Res. 2011, 127:70-74.
3. Ma Q., Cornelli U., Hanin I., Jeske W.P., Linhardt R.J., Walenga J.M., Fareed J., Lee J.M. Heparin oligosaccha rides as potential therapeutic agents in senile dementia. Curr. Pharm. Des. 2007, 13:1607-1616.
4. Yang H.S., Bhang S.H., Hwang J.W., Kim D.I., Kim B.S. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. Tissue Eng. Part A 2010, 16:2113-2119.
5. Lewis E.J., Xu X.L. Abnormal glomerular permeability characteristics in diabetic nephropathy implications for the therapeutic use of low-molecular weight heparin. Diabetes Care 2008, 31:S202-S207.
6. Zacharski L.R., Lee A.Y.Y. Heparin as an anticancer therapeutic. Expert Opin. Investig. Drug 2008, 17:1029-1037.
7. Xu Y.M., Masuko S., Takieddin M., Xu H.M., Liu R.P., Jing J., Mousa S.A., Linhardt R.J., Liu J. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 2011, 334:498-501.
8. Linhardt R.J., Gunay N.S. Production and chemical processing of low molecular weight heparins. Semin. Thromb. Hemost. 1999, 25:5-16.
9. Xiao Z.P., Tappen B.R., Ly M., Zhao W.J., Canova L.P., Guan H.S., Linhardt R.J. Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin. J. Med. Chem. 2011, 54:603-610.
10. Linhardt R.J., Galliher P.M., Cooney C.L. Polysaccharide lyases. Appl. Biochem. Biotechnol. 1986, 12:135-176.
11. Desai U.R., Wang H.M., Linhardt R.J. Substrate-specificity of the heparin lyases from flavobacterium-heparinum. Arch. Biochem. Biophys. 1993, 306:461-468.
12. Desai U.R., Wang H.M., Linhardt R.J. Specificity studies on the heparin lyases from flavobacterium-heparinum. Biochemistry - US 1993, 32:8140-8145.
13. Linhardt R.J., Turnbull J.E., Wang H.M., Loganathan D., Gallagher J.T. Examination of the substrate-specificity of heparin and heparan-sulfate lyases. Biochemistry - US 1990, 29:2611-2617.
14. Nader H.B., Porcionatto M.A., Tersariol I.L.S., Pinhal M.A.S., Oliveira F.W., Moraes C.T., Dietrich C.P. Purification and substrate-specificity of heparitinase-I and heparitinase-II from flavobacterium-heparinum - analyses of the heparin and heparan-sulfate degradation products by C-13 NMR-spectroscopy. J. Biol. Chem. 1990, 265:16807-16813.
15. Shaya D., Zhao W.J., Garron M.L., Xiao Z.P., Cui Q.Z., Zhang Z.Q., Sulea T., Linhardt R.J., Cygler M. Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate. J. Biol. Chem. 2010, 285:20051-20061.
16. Karamanos N.K., Vanky P., Tzanakakis G.N., Tsegenidis T., Hjerpe A. Ion-pair high-performance liquid chromatography for determining disaccharide composition in heparin and heparan sulphate. J. Chromatogr. A 1997, 765:169-179.
17. Korir A.K., Lirntiaco J.F.K., Gutierrez S.M., Larive C.K. Ultraperformance ion-pair liquid chromatography coupled to electrospray time-of-flight mass spectrometry for compositional profiling and quantification of heparin and heparan sulfate. Anal. Chem. 2008, 80:1297-1306.
18. Zhang F.M., Yang B., Ly M., Solakyildirim K., Xiao Z.P., Wang Z.Y., Beaudet J.M., Torelli A.Y., Dordick J.S., Linhardt R.J. Structural characterization of heparins from different commercial sources. Anal. Bioanal. Chem. 2011, 401:2793-2803.
19. Galeotti F., Volpi N. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone. Anal. Chem. 2011, 83:6770-6777.
20. Saad O.M., Leary J.A. Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal. Chem. 2003, 75:2985-2995.
21. Saad O.M., Ebel H., Uchimura K., Rosen S.D., Bertozzi C.R., Leary J.A. Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. Glycobiology 2005, 15:818-826.
22. Kinoshita A., Sugahara K. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: application to disaccharide composition analysis and exosequencing of oligosaccharides. Anal. Biochem. 1999, 269:367-378.
23. Camara J.E., Satterfield M.B., Nelson B.C. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry. J. Pharm. Biomed. Anal. 2007, 43:1706-1714.
24. Ruiz-Calero V., Puignou L., Galceran M.T. Use of reversed polarity and a pressure gradient in the analysis of disaccharide composition of heparin by capillary electrophoresis. J. Chromatogr. A 1998, 828:497-508.
25. Militsopoulou M., Lamari F.N., Hjerpe A., Karamanos N.K. Determination of twelve heparin- and heparan sulfate-derived disaccharides as 2-aminoacridone derivatives by capillary zone electrophoresis using ultraviolet and laser-induced fluorescence detection. Electrophoresis 2002, 23:1104-1109.
26. Brustkern A.M., Buhse L.F., Nasr M., Al-Hakim A., Keire D.A. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests. Anal. Chem. 2010, 82:9865-9870.
27. Jones C.J., Membreno N., Larive C.K. Insights into the mechanism of separation of heparin and heparan sulfate disaccharides by reverse-phase ion-pair chromatography. J. Chromatogr. A 2010, 1217:479-488.
28. Jones C.J., Beni S., Larive C.K. Understanding the effect of the counterion on the reverse-phase ion-pair high-performance liquid chromatography (RPIP-HPLC) resolution of heparin-related saccharide anomers. Anal. Chem. 2011.
29. Solakyildirim K., Zhang Z.Q., Linhardt R.J. Ultraperformance liquid chromatography with electrospray ionization ion trap mass spectrometry for chondroitin disaccharide analysis. Anal. Biochem. 2010, 397:24-28.
30. Doneanu C.E., Chen W.B., Gebler J.C. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry. Anal. Chem. 2009, 81:3485-3499.
31. Zhang Z.Q., Xie J., Liu H.Y., Liu J., Linhardt R.J. Quantification of heparan sulfate disaccharides using ion-pairing reversed-phase microflow high-performance liquid chromatography with electrospray ionization trap mass spectrometry. Anal. Chem. 2009, 81:4349-4355.
32. Linker A., Hovingh P. Isolation and characterization of oligosaccharides obtained from heparin by action of heparinase. Biochemistry - US 1972, 11:563.
33. Skelley A.M., Mathies R.A. Rapid on-column analysis of glucosamine and its mutarotation by microchip capillary electrophoresis. J. Chromatogr. A 2006, 1132:304-309.
34. Casu B., Gennaro U. Conductimetric method for determination of sulfate and carboxyl groups in heparin and other mucopolysaccharides. Carbohydr. Res. 1975, 39:168-176.
35. Eldridge S.L., Higgins L.A., Dickey B.J., Larive C.K. Insights into the capillary electrophoresis separation of heparin disaccharides from nuclear magnetic resonance, pK(a), and electrophoretic mobility measurements. Anal. Chem. 2009, 81:7406-7415.
36. Blasko A., Bunton C.A., Bunel S., Ibarra C., Moraga E. Determination of acid dissociation constants of anomers of amino sugars by H-1 NMR spectroscopy. Carbohydr. Res. 1997, 298:163-172.
37. Guerrini M., Guglieri S., Naggi A., Sasisekharan R., Torri G. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin. Thromb. Hemost. 2007, 33:478-487.
38. McClellan J.E., Costello C.E., O'Connor P.B., Zaia J. Influence of charge state on product ion mass spectra and the determination of 4S/6S sulfation sequence of chondroitin sulfate oligosaccharides. Anal. Chem. 2002, 74:3760-3771.
39. Yagami T., Kitagawa K., Aida C., Fujiwara H., Futaki S. Stabilization of a tyrosine O-sulfate residue by a cationic functional group: formation of a conjugate acid-base pair. J. Pept. Res. 2000, 56:239-249.
40. Yang B., Weyers A., Baik J.Y., Sterner E., Sharfstein S., Mousa S.A., Zhang F., Dordick J.S., Linhardt R.J. Ultra-performance ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for heparin disaccharide analysis. Anal. Biochem. 2011, 415:59-66.